Gene · 3913
Papers4,188
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
401 to 420 of 4,188
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A perfusion-based three-dimensional cell culture system to model alveolar rhabdomyosarcoma pathological features. | Sci Rep | 2023 | 37296184 | PubTator, text mining | PubMed |
| 3D-bioprinting of patient-derived cardiac tissue models for studying congenital heart disease. | Front Cardiovasc Med | 2023 | 37293290 | PubTator, text mining | PubMed |
| Reliable Identification and Interpretation of Single-Cell Molecular Heterogeneity and Transcriptional Regulation using Dynamic Ensemble Pruning. | Adv Sci (Weinh) | 2023 | 37290050 | PubTator, text mining | PubMed |
| The role of ADAM8 in the mechanophenotype of MDA-MB-231 breast cancer cells in 3D extracellular matrices. | Front Cell Dev Biol | 2023 | 37287457 | PubTator, text mining | PubMed |
| Harnessing male germline epigenomics for the genetic improvement in cattle. | J Anim Sci Biotechnol | 2023 | 37277852 | PubTator, text mining | PubMed |
| MiR-29a-deficiency causes thickening of the basilar membrane and age-related hearing loss by upregulating collagen IV and laminin. | Front Cell Neurosci | 2023 | 37275774 | PubTator, text mining | PubMed |
| Comprehensive Glycoprofiling of Oral Tumors Associates N-Glycosylation With Lymph Node Metastasis and Patient Survival. | Mol Cell Proteomics | 2023 | 37268159 | PubTator, text mining | PubMed |
| Microenvironment commits breast tumor ECs to dedifferentiation by micro-RNA-200-b-3p regulation and extracellular matrix remodeling. | Front Cell Dev Biol | 2023 | 37261072 | PubTator, text mining | PubMed |
| RTK signalling promotes epithelial columnar cell shape and apical junction maintenance in human lung progenitor cells. | Development | 2023 | 37260147 | PubTator, text mining | PubMed |
| Alveolar epithelial cells are competent producers of interstitial extracellular matrix with disease relevant plasticity in a human in vitro 3D model. | Sci Rep | 2023 | 37258541 | PubTator, text mining | PubMed |
| Co-administration of extracellular matrix-based biomaterials with neural stem cell transplantation for treatment of central nervous system injury. | Front Neurosci | 2023 | 37255752 | PubTator, text mining | PubMed |
| Accelerated replicative senescence of ataxia-telangiectasia skin fibroblasts is retained at physiologic oxygen levels, with unique and common transcriptional patterns. | Aging Cell | 2023 | 37254625 | PubTator, text mining | PubMed |
| Cell-derived nanovesicles from mesenchymal stem cells as extracellular vesicle-mimetics in wound healing. | Acta Pharm Sin B | 2023 | 37250164 | PubTator, text mining | PubMed |
| Collagen Fibril Orientation Instructs Fibroblast Differentiation Via Cell Contractility. | Adv Sci (Weinh) | 2023 | 37249413 | PubTator, text mining | PubMed |
| New insights from trio whole-exome sequencing in the children with kidney disease: A single-center retrospective cohort study. | Mol Genet Genomic Med | 2023 | 37248651 | PubTator, text mining | PubMed |
| Marine Collagen-Based Bioink for 3D Bioprinting of a Bilayered Skin Model. | Pharmaceutics | 2023 | 37242573 | PubTator, text mining | PubMed |
| Circulating miRNA-192 and miR-29a as Disease Progression Biomarkers in Hepatitis C Patients with a Prevalence of HCV Genotype 3. | Genes (Basel) | 2023 | 37239415 | PubTator, text mining | PubMed |
| Enhanced chondrogenic differentiation of iPS cell-derived mesenchymal stem/stromal cells via neural crest cell induction for hyaline cartilage repair. | Front Cell Dev Biol | 2023 | 37234772 | PubTator, text mining | PubMed |
| Understanding and targeting resistance mechanisms in cancer. | MedComm (2020) | 2023 | 37229486 | PubTator, text mining | PubMed |
| Tibial plateau fracture and RNA sequencing with osteogenesis imperfecta: a case report. | Front Endocrinol (Lausanne) | 2023 | 37229455 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3913/papers?page=21